Matthew Lang

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Matthew Lang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Lang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Business Officer Common Stock 163K $114K $2.28 10 Feb 2025 Direct
Metsera, Inc. CHIEF LEGAL OFFICER Common Stock 0 $0 $52.33 13 Nov 2025 Direct
Lyell Immunopharma, Inc. Chief Business Officer Option (right to buy) 56.3K 10 Feb 2025 Direct
Metsera, Inc. CHIEF LEGAL OFFICER Restricted Stock Unit 12.5K 13 Nov 2025 Direct
Metsera, Inc. CHIEF LEGAL OFFICER Stock Option (right to buy) 0 13 Nov 2025 Direct
Myovant Sciences Ltd. General Counsel & Corp. Secy. Common Shares 0 $27.00 10 Mar 2023 Direct
Myovant Sciences Ltd. General Counsel & Corp. Secy. Performance Stock Unit 0 10 Mar 2023 Direct
Myovant Sciences Ltd. General Counsel & Corp. Secy. Stock Options (Right to Buy) 0 10 Mar 2023 Direct

Insider Reports Filed by Matthew Lang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MTSR Metsera, Inc. 13 Nov 2025 4 $0 4 CHIEF LEGAL OFFICER 13 Nov 2025, 21:20
MTSR Metsera, Inc. 20 May 2025 1 $0 4 Chief Legal Officer 22 May 2025, 19:37
MTSR Metsera, Inc. 28 Apr 2025 0 $0 3 Chief Legal Officer 30 Apr 2025, 21:08
LYEL Lyell Immunopharma, Inc. 10 Feb 2025 3 $0 4 Chief Business Officer 26 Feb 2025, 19:36
LYEL Lyell Immunopharma, Inc. 09 Feb 2024 2 $0 4 Chief Business Officer 13 Feb 2024, 20:25
LYEL Lyell Immunopharma, Inc. 10 Aug 2023 1 $0 4 Chief Business Officer 11 Aug 2023, 16:24
LYEL Lyell Immunopharma, Inc. 01 Jul 2023 0 $0 3 Chief Business Officer 20 Jul 2023, 13:07
MYOV Myovant Sciences Ltd. 10 Mar 2023 8 $0 4 General Counsel & Corp. Secy. 10 Mar 2023, 08:29
MYOV Myovant Sciences Ltd. 18 Jan 2023 1 -$34.2K 4 General Counsel & Corp. Secy. 20 Jan 2023, 15:36
MYOV Myovant Sciences Ltd. 04 Jan 2023 1 -$74.8K 4 General Counsel & Corp. Secy. 05 Jan 2023, 16:20
MYOV Myovant Sciences Ltd. 18 Oct 2022 1 -$48.7K 4 General Counsel & Corp. Secy. 20 Oct 2022, 16:51
MYOV Myovant Sciences Ltd. 04 Oct 2022 1 -$89.8K 4 General Counsel & Corp. Secy. 06 Oct 2022, 16:26
MYOV Myovant Sciences Ltd. 12 Aug 2022 2 -$569K 4 General Counsel & Corp. Secy. 16 Aug 2022, 17:01
MYOV Myovant Sciences Ltd. 18 Jul 2022 1 -$24.9K 4 General Counsel & Corp. Secy. 20 Jul 2022, 16:38
MYOV Myovant Sciences Ltd. 06 Jul 2022 1 -$49.6K 4 General Counsel & Corp. Secy. 08 Jul 2022, 16:08
MYOV Myovant Sciences Ltd. 19 Apr 2022 1 -$83.6K 4 General Counsel & Corp. Secy. 21 Apr 2022, 16:28
MYOV Myovant Sciences Ltd. 15 Apr 2022 1 $0 4 General Counsel & Corp. Secy. 19 Apr 2022, 16:49
MYOV Myovant Sciences Ltd. 05 Apr 2022 1 -$33.6K 4 General Counsel & Corp. Secy. 07 Apr 2022, 16:19
MYOV Myovant Sciences Ltd. 04 Jan 2022 1 -$72.8K 4 General Counsel & Corp. Secy. 06 Jan 2022, 15:46
MYOV Myovant Sciences Ltd. 05 Oct 2021 1 -$144K 4 General Counsel & Corp. Secy. 07 Oct 2021, 16:02
MYOV Myovant Sciences Ltd. 09 Jul 2021 1 -$150K 4 General Counsel & Corp. Secy. 13 Jul 2021, 16:21